SCHEMBL8504369

SCHEMBL8504369

CCCCc1c(F)ccc2c1C(C(=O)N(CC(F)(F)F)N1CC(N3C(=O)c4ccccc4C3=O)C1)c1cc(F)ccc1-2

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ KCNA5 P22460 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8666049 0.94 L3MBTL1 (0.34) HTTL3MBTL1
SCHEMBL8484436 0.93 L3MBTL1 (0.37) HTTL3MBTL1
SCHEMBL8500946 0.84 CCR3 (0.36) —
SCHEMBL8479389 0.84 DPP4 (0.38) —
SCHEMBL8665216 0.80 CCR3 (0.39) —
SCHEMBL8504363 0.79 KCNA5 (0.30) KCNA5
SCHEMBL8666043 0.75 HTT (0.33) HTTL3MBTL1
SCHEMBL8484431 0.75 L3MBTL1 (0.35) HTTL3MBTL1
SCHEMBL8504367 0.73 KCNA5 (0.32) HTTL3MBTL1KCNA5
SCHEMBL8502235 0.71 AOC3 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5885983-A ANTICHOLESTEROL AGENTS, ANTILIPOLYTIC AGENTS, ANTILIPEMIC AGENTS FOR TREATING HYPERLIPEMIA, ATHEROSCLEROSIS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-23 — — US disclosed
Send feedback